Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

Presentation THT Abstracts 2025

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Presenter: John Mohr

February 11, 2025

Presentation THT 2025

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Presenter: John Mohr

February 11, 2025

Presentation THT 2025

Natriuretic Response to Furosemide: The Role of Hypochloremia and Chloride Supplementation: A Sub Analysis of the SALT-HF Trial

Presenter: Julio Núñez Villota

February 11, 2025

News Conference News AHA 2024

Nasal Bumetanide Safe, Effective in Healthy Adults

Yael L. Maxwell

November 18, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Conference News ESC Heart Failure 2024

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Michael O'Riordan

May 13, 2024

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Conference News ESC Heart Failure 2023

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

Shelley Wood

May 25, 2023

Presentation THT 2023

Timeframe of Heart Failure Symptom Improvements After Subcutaneous Furosemide: Data from the AT HOME Pilot Study

Presenter: James Udelson

March 20, 2023

Presentation THT 2023

ASSOCIATION OF FUROSEMIDE VS TORSEMIDE WITH FIVE-YEAR NEUROCOGNITIVE OUTCOMES IN PATIENTS WITH HEART FAILURE

Presenter: Alec Miller

March 20, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News ESC Heart Failure 2019

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Shelley Wood

May 28, 2019

News Conference News ESC Heart Failure 2019

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Shelley Wood

May 25, 2019

News Daily News

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Todd Neale

March 25, 2018

News Industry News

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

November 03, 2015

Advertisement

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Natriuretic Response to Furosemide: The Role of Hypochloremia and Chloride Supplementation: A Sub Analysis of the SALT-HF Trial

Nasal Bumetanide Safe, Effective in Healthy Adults

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

Timeframe of Heart Failure Symptom Improvements After Subcutaneous Furosemide: Data from the AT HOME Pilot Study

ASSOCIATION OF FUROSEMIDE VS TORSEMIDE WITH FIVE-YEAR NEUROCOGNITIVE OUTCOMES IN PATIENTS WITH HEART FAILURE

TCTMD’s Top 10 Most Popular Stories for November 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content